Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Recruiting · NCT06439836 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma | Recruiting | Phase 1 | 2026-09-21 | NCT06439836 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope Comprehensive Cancer Center | Duarte | United States | 263 |
| Emory Saint Joseph's Hospital | Atlanta | United States | 175 |
| Emory University Hospital Midtown | Atlanta | United States | 246 |
| Emory University Hospital/Winship Cancer Institute | Atlanta | United States | 299 |
| Mount Sinai Hospital | New York | United States | 225 |
| NYP/Weill Cornell Medical Center | New York | United States | 128 |
| UC Irvine Health/Chao Family Comprehensive Cancer Center | Orange | United States | 189 |
| UC San Diego Moores Cancer Center | La Jolla | United States | 199 |
| UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care | Irvine | United States | 95 |
| University of Miami Miller School of Medicine-Sylvester Cancer Center | Miami | United States | 232 |
| UT Southwestern/Simmons Cancer Center-Dallas | Dallas | United States | 273 |